In: Accounting
Q1.
Company A
Location : China
Virus discovered in November 2019
Financial reporting period ends on October 31st 2019
All events occuring after 31st October 2019 till the Financial Statements are issued by the management are called subsequent events. The Coronavirus crisis is a subsequent event in that respect as it was identified in November 2019. The question is to judge whether there where any conditions that existed as on 31st October, that indicated a viral outbreak. I would say no, as even if a few cases were reported here and there, there was no reliable news indication that a virus of this scale that can affect business existed as at the end of the reporting period. So it is not an adjusting event.
However, it is a material non adjusting event as this crisis has the potential to affect business deeply. Hence it has to be disclosed in the Financial Statements.
Company B
Location : UK
Virus discovered in February 2020
Financial reporting period ends on December 31st 2019
Coronavirus is a subsequent event. A prudent management that follows the news closely would observe that with the outbreak declared in China and slowly spreading to other countries, it is safe to say that conditions indicating Coronavirus reaching UK does exist as at December end, but most companies would overlook this as a single case was not reported in UK and nobody would have guessed it. However, this is an adjusting event as far as balance sheets of British Companies are concerned. Amounts (especially if the company has trade links with China) will have to be adjusted and provisions may have to be created.
Company C
Location: Ghana
Virus discovered in March 2020
Financial reporting period ends on 31st March 2020
In this case, there is no question of subsequent event, as the virus was reported even before the financials could be closed. Hence, necessary corrections and disclosures must be made. IAS 10 per say does not apply in this scenario as it is not a subsequent event.
Q2.
Airline Company
Coronavirus has brought many businesse to a standstill. Due to its virulent nature and ill effects on health of people, major lockdowns have been declared in all countries. This means that incomes may reduce and spending will be rationed by people on only essential services. It is obvious that movement of people will be heavily restricted atleast in the coming 12 months if not more. This will gravely affect the Airline industry in many ways.
The Airline industry is one where capital costs are already large and with rising prises on AirTurbine Fuel, the profit margins are quite low unless you fly with more than 60% capacity atleast. The management will have to analyse key performance and financial ratios to see if the company has enough resources to tide over the crisis. It is to be understood that there will not be ready cash to pay suppliers and this may cause various vendors to cancel contracts with the company. Customers will be very very low and low revenues may not allow the company to cover the fixed costs. It would be difficult to seek Govt. help as their resources would be directed towards the Health and welfare sector due to its need. The only way in which airline industry can be saved is if it has enough finance to tide over the crisis for now.
Hence,as a management advisor I would doubt the ability to continue as a going concern for this company. As per IAS 1, the financial statements cannot be prepared using Going concern basis but rather liquidity basis.
Pharmaceutical Company
In the case of a Pharma Company, the conditions seem favourable.
With the rise in Corona cases, medical facilites, equipments and
drugs are high in demand in every country, with the country's Govt.
ready to pay large sums or even provide grants for procuring life
saving drugs and mainly spending on research to test and develop a
vaccine that can beat the virus.
If this Pharma Company can make optimum use of their resources and knowledge to maybe even develop a drug, a patent would be highly profitable. This is also one of the reasons if you look at stock market indexes, Pharma Companies have been riding on a high. Obviously the costs for developing a drug and capital required need to be considered.
I would suggest The Pharma Company to prepare its balance sheet on Going Concern basis as the Corona outbreak won't break the company yet assuming all other financial indicators (like normal companies) are favourable.